New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Berry Genomics, ...

Market conditions remain tough for biotech companies, but Twist continues to perform well compared to peers. Twist Bioscience's second quarter results were strong, driven by NGS demand, and the ...

2022 saw a surge of interest and competition in the next-gen sequencing (NGS) industry, as established companies were joined by a hungry group of new platforms. Today, researchers who sequence DNA ...

[more than 13% of patients with advanced NSCLC and an aSV] "would have experienced a meaningful delay of several weeks or more if RNA-NGS and DNA-NGS had been performed sequentially rather than ...

Genomics offers a foundation for understanding disease, but proteomics reveals invaluable insights by offering a real-time look at protein activity. Proteogenomic studies are advancing thanks to ...

On July 23, 2025, the National Geodetic Survey (NGS) sent a news notice announcing the rollout plan for remaining NSRS modernization products, including OPUS Products Changes, and on June 11, 2025, ...